INTRODUCTION
Upon brain ischemia, application of thrombolytic agents to induce reperfusion is the only effective therapeutic intervention proven. Liberation of excess glutamate upon ischemia is the direct trigger of neuronal cell death; however, as the cellular source of glutamate and its release mechanism were unidentified, targeted intervention to suppress glutamate release has mostly been unsuccessful (but see Hines and Haydon, 2013) . We focused on the astrocytes of the glial cell population as they are the first responders to ischemic stress (Rossi et al., 2007) . When aerobic metabolism shuts down as a consequence of oxygen and glucose deprivation, lactate production from glycogen stored predominantly in glial cells continues (Cataldo and Broadwell, 1986; Schurr et al., 1997) , which leads to severe acidosis (Mutch and Hansen, 1984) . Neuronal cell death via glutamate excitotoxicity follows (Lau and Tymianski, 2010) . We simply connected these two events and hypothesized that glial acidosis triggers glial glutamate release. Based on this hypothesis, we sought an optogenetic intervention to control glutamate release upon ischemia and to understand the cellular mechanisms leading to its excess release.
RESULTS

OGD Induces Glutamate Release and Acidosis
Using acute cerebellar brain slices, ischemia was mimicked by oxygen and glucose deprivation (OGD) from continuously perfused artificial cerebrospinal fluid (ACSF) (Hamann et al., 2005) . Neuronal cell health was monitored by whole-cell patchclamp recordings from Purkinje cells (PCs) ( Figure 1A ). Shortly after the onset of OGD, transient burst firing occurred, which was followed closely by a plateau depolarization. These events could be considered as preludes to the eventual death of neurons. To monitor the excitatory drive evoked by OGD in isolation, we recorded PCs in voltage clamp and applied picrotoxin (PIC) to block inhibitory GABA A receptors. To exclude effects from neuronal transmitter release and focus on the glial contribution to ischemic stress, we also applied tetrodotoxin (TTX) and Cd 2+ to block action potentials and voltage-gated Ca 2+ channels, respectively. Within minutes, inward current developed, suggesting that OGD triggered release of excitatory substance from nonsynaptic sources, presumably from glia ( Figure 1B ). Whether this inward current is evoked by glutamate was examined with an AMPA receptor blocker alone (GYKI) or with a cocktail of glutamate receptor and transporter (GluR/T) blockers (NBQX, D-AP5, LY363785, and TBOA) ( Figure 1C ). OGD-induced inward current was significantly blocked in both cases, demonstrating that the majority of the inward current is due to glutamate. It should be noted, however, that some current remained, suggesting that OGD also triggers effects other than glutamate release. Our previous report has suggested that glial glutamate release can occur through 4,4'-diisothiocyanostilbene-2,2 0 -disulphonic acid (DIDS)-sensitive anion channels . Application of DIDS also partially inhibited the OGD-induced inward currents. These results suggest that release through DIDS-sensitive mechanisms could be one of the primary sources of excess glutamate liberation upon ischemia (Camacho et al., 2006; Liu et al., 2006; Seki et al., 1999) , although DIDS-insensitive mechanisms also likely have a role. It has also been reported that glutamate release can occur through reversal of glutamate transporters. Extracellular TBOA has been suggested to block glutamate transporter reversal (Phillis et al., 2000) ; however, the development of the OGDinduced current was only accelerated by TBOA ( Figure S1A available online), likely due to the slower clearance of the released glutamate by blocking of the uptake by TBOA. Therefore, we were unable to assess the relative contributions of each component of glutamate release mechanisms.
Based on previous reports indicating the presence of pHdependent anion channels that are DIDS sensitive (Cavelier and Attwell, 2005; Lambert and Oberwinkler, 2005; Zifarelli et al., 2008) and pH-dependent amino acid transporters (Sakai et al., 2003; Weiss et al., 2005) , we next sought to examine the causal link between glial acidification and glutamate release. First, we verified that glial acidification indeed occurs upon OGD in acute cerebellar slices by using a pH-sensitive fluorescence dye, SNARF-5F AM ( Figure 1D and Figures S1B and S1C). OGD elicited rapid reduction of SNARF-5F fluorescence ratio in cerebellar Bergmann glial cells (BGs), indicating intracellular acidification. Cells other than BGs were also acidified and the time course of acidification was examined in granule cells (GCs), which have similar soma size as the BGs. Interestingly, the onset of acidification was significantly faster in BGs than GCs ( Figures S1D and S1E ).
Acidification Is the Trigger for Glial Glutamate Release
We next attempted to bypass the OGD process and directly acidify glial cells by optogenetic activation of ChR2. ChR2 is a light-sensitive cation channel and it is usually considered as a tool to optically excite cell activity via membrane depolarization. However, contrary to other excitatory channels such as Na + channels or ionotropic glutamate receptor channels, ChR2 has much more permeability to H + than Na + (Nagel et al., 2003) . Thus, ChR2 could be considered as an optogenetic tool for manipulation of intracellular pH. We employed a transgenic mouse line in which highly light-sensitive mutant (C128S [Berndt et al., 2009] ) of ChR2 was selectively expressed in astrocytes including BGs using the tetracycline transactivator (tTA)-tet operator (tetO) system . To confirm proton influx by ChR2 opening, we measured photocurrents from BGs with intracellular and extracellular cations mostly replaced with N-Methyl-D-glucamine (NMDG), a cation with little permeability to ChR2; thus, the only cation left permeable was proton 
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Optogenetic Glial Countering of Ischemic Damage ( Figure 2A ). Decreasing pH means increasing proton concentration. Decreasing the external pH from 7.4 to 5.0 enhanced the photocurrent, whereas increasing the pH from 7.4 to 9.0 reduced it. These data suggest that our C128S-modified ChR2 expressed in BGs are also permeable to proton, although it is possible that ChR2 channel opening itself could be regulated by external pH.
To verify proton influx through ChR2(C128S) in normal intracellular and extracellular solutions, we performed pH imaging, and BG acidification by ChR2(C128S) photoactivation was confirmed ( Figure 2B ). These results indicate that proton influx occurs upon ChR2 activation; however, if trace amount of ChR2 is also expressed in intracellular compartments, proton could enter the cytosol from these sources as well (Gourine et al., 2010) . We have shown previously that glial ChR2 photoactivation resulted in glutamate release that could be detected as AMPA receptor-mediated current in PCs . Considering the above results, it is possible that proton influx direct triggers glutamate release; however, it is also possible that depolarization itself caused by the ChR2 photoactivation or the very small amount of Ca 2+ influx via ChR2 openings could be the actual trigger. Therefore, we devised a way to cause different amounts of acidification with the same amount of proton influx by manipulating the intracellular pH buffering capacity. Intracellular pH is considered to be buffered by HCO 3 À and depriving extracellular HCO 3 À would probably cause efflux of intracellular HCO 3 À and result in low buffering capacity of the intracellular pH (Zhang et al., 2010) . Consistent with this idea, acidification measured by SNARF-5F imaging was significantly stronger in extracellular 5 mM HEPES buffer solution compared with extracellular NaHCO 3 buffer solution, even though both solutions were adjusted to the same pH ( Figure 2B , right). No significant difference was found in the amplitude of ChR2-induced BG depolarization upon switching from NaHCO 3 -based to HEPESbased solution ( Figure 2C , top); however, glial ChR2-photoactivated PC current was significantly increased ( Figure 2C , bottom). The PC current in HEPES was mostly blocked by GYKI ( Figure 2D ), as in the normal NaHCO 3 solution . No current was induced with photostimulation in BGs or PCs from mice that lack the expression of optogenetic tools ( Figure S2A ). Glutamate sensitivity of PC currents was not increased by switching the external solutions ( Figure 2E ). These observations imply that stronger intracellular glial acidification leads to larger amount of glutamate release. To test the H + -triggered glutamate release hypothesis further, we employed an alternative method to induce intracellular acidification, which was to locally pressure (puff) apply a weak membrane-permeable acid, acetate. This did not induce depolarization of BGs but did evoke a slow inward current in PCs, which was not detected in the presence of GYKI ( Figure S2B ). To further exclude (A) Astrocyte-specific ChR2(C128S)-expressing mice were used. H + permeability of ChR2(C128S) expressed on BGs was assessed by changing the extracellular pH from 7.4 to 5.0 (top) or 9.0 (bottom). Photocurrent amplitude at 100-200 ms from the blue light onset was significantly increased in pH 5.0 (*p < 0.01, n = 5, paired t test) and decreased in pH 9.0 (*p < 0.01, n = 8, paired t test). Blue and yellow light opens and closes the ChR2(C128S) channel, respectively. (B) pH imaging of BGs with SNARF-5F. A single pulse of blue light opened the ChR2(C128S) channel for a prolonged time and intracellular acidification was induced. The acidification was stronger in HEPES compared to NaHCO 3 external buffer (*p < 0.01, n = 12 each, Student's t test). (C) BG depolarization amplitude via ChR2(C128S) photoactivation was not affected by the external pH buffer (p = 0.07, n = 3, paired t test, top), whereas glial ChR2-photoactivated PC currents became significantly larger by altering the buffer from NaHCO 3 to HEPES compared to NaHCO 3 to NaHCO 3 (*p < 0.05, n = 7 and 3, Student's t test). (D) Application of GYKI, an AMPA receptorspecific antagonist, blocked glial ChR2-photoactivated PC current in HEPESbased solution. (E) Exchanging the extracellular solution from NaHCO 3 -based to HEPES-based buffer did not increase PC currents in response to glutamate (200 mM) puff application (n = 5) but rather decreased it. Although we are uncertain about the mechanism underlying this decrease, this result indicates that the increase in the glial ChR2-photoactivated PC current upon exchanging the extracellular solutions ( Figure 2C ) was not due to the increase in the glutamate sensitivity of PC glutamate receptors. All recordings were in TTX, Cd 2+ , and PIC. Error bars represent SEM. See also Figure S2 .
depolarization as the primary trigger of glial glutamate release, we examined the effect of puff application of high concentration of K + . Similar to ChR2 photoactivation, high K + application caused BG depolarization, but the current recorded from PCs was not altered by application of GYKI or NBQX ( Figure S2C) ; thus, glutamate is not likely to be released as a consequence of BG depolarization or by high extracellular K + in the presence of TTX and Cd
2+
. The Ca 2+ permeability of ChR2 is very low unless it is specifically modified (Kleinlogel et al., 2011; Li et al., 2012) ; thus, Ca 2+ influx through these channels is not likely to be sufficient to drive glial glutamate release (Woo et al., 2012) .
To verify this idea, we omitted Ca 2+ and added EGTA to the extracellular solution. The glial ChR2-photoactivated PC current remained uninhibited in this condition ( Figure S2D) . It is still possible that intracellular Ca 2+ increase could occur subsequent to intracellular acidification (Orlowski et al., 2011) . To evaluate whether Ca 2+ is involved in the signaling pathway, we strongly buffered intracellular Ca 2+ with BAPTA-AM. Although BAPTA-AM was sufficient to strongly suppress neuronal synaptic release of glutamate ( Figure S2E ), it did not significantly alter glial ChR2-photoactivated PC currents ( Figure S2F 
Countering Glial Acidosis Inhibits Neuronal Damage
If glial acidification were the key trigger of glutamate release upon ischemia, countering acidification with alkalization should be able to inhibit glutamate release and excitotoxicity. To selectively increase glial intracellular pH, we generated a mouse line in which astrocyte population of glia, including BGs, specifically expresses ArchT, a light-sensitive outward proton pump (Han et al., 2011) using the tTA-tetO system (Tsunematsu et al., 2013) . Immunofluorescence and immunogold electron microscopic observations confirmed specific expression of ArchT in BGs ( Figures 3A and 3B and Figure S3A ). ArchT photoactivation produced outward currents and hyperpolarization in BGs in voltage-and current-clamp modes, respectively ( Figure 3C ). pH imaging also showed that ArchT photoactivation reliably induced alkalization of BGs ( Figure 3D ). Glial ArchT photoactivation dramatically inhibited OGD-induced inward currents in PCs ( Figure 3E ). Similar results were obtained at near-physiological temperature ( Figure S3B ). Glial ArchT photoactivation alone in control condition did not evoke any current in PCs and the effect was only evident in OGD ( Figure 3F) ; thus, proton efflux from glia or other ionic change does not directly produce any current in PCs. Furthermore, the blocking effect of glial ArchT photoactivation on OGD-induced PC currents was nearly equal to that of GluR/T blocker application ( Figure 3E , middle) and was occluded in the presence of GluR/T blockade ( Figure 3E, right) . As DIDS could only block half of the OGD-induced current ( Figure 1C ) and, as the ArchT effect was only partially occluded by DIDS ( Figure S3C Immunogold EM of EGFP in the bigenic mice. EGFP was confirmed to be localized only in the astrocytes (288, 0, 0, and 1 immunogolds in identified astrocyte, presynaptic, postsynaptic, and unidentifiable profiles, respectively). Scale bars indicate 500 nm in low-(left) and high-(right) magnified images. (C) Typical current (left) and voltage (right) responses of BGs to ArchT photoactivation (yellow). Right: average amplitudes of outward current (n = 9) and hyperpolarization (n = 6). (D) pH imaging of a BG showed that alkalization was induced with glial ArchT photoactivation. Right: results summarized (n = 7). (E) OGD-induced PC currents were reduced by glial ArchT photoactivation (time constant to reach equilibrium = 1.6 ± 0.2 s, n = 8). The effect was not significantly different from the blocking effect of GluR/T blockers (p = 0.27, n = 8, 14, Student's t test). ArchT photoactivation effect on PC was significantly reduced in the presence of GluR/T blockers (*p < 0.05, n = 5, paired t test). (F) Glial ArchT-photoactivated PC currents were not detected under control condition, whereas the glial ArchT photoactivation generated outward PC currents during OGD. Average amplitudes of the outward current (9.5-10 s after yellow light application) were summarized (n = 7 each). Recordings in (D), (E), and (F) were in the presence of TTX, Cd 2+ , and PIC. Error bars represent SEM. See also Figure S3 .
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Optogenetic Glial Countering of Ischemic Damage glial glutamate release mechanisms, both of which are pH sensitive. As glutamate uptake by glutamate transporters is voltage dependent (Bergles et al., 1997) , it is possible that glutamate release is not suppressed but the uptake is facilitated in glia, which is hyperpolarized by ArchT photoactivation. To examine this possibility, we induced OGD in the presence of TBOA. Glial ArchT photoactivation blocked OGD-induced PC currents similarly, even in the presence of TBOA ( Figure S3D ). Taken together, these data suggest that glial pH change is an upstream causal factor of glutamate release upon ischemia. We next examined whether intermittent glial ArchT photoactivation could prevent deterioration of the healthiness of neurons upon ischemia. Excitatory drive recorded from PCs in voltage clamp rapidly increased upon OGD and over 1 nA of inward current was observed within 20 min. We next introduced intermittent glial ArchT photoactivation after detecting inward currents of more than 300 pA. Further development of inward current was prominently suppressed ( Figure 4A ). The inward current could not be suppressed completely, suggesting the presence of additional unidentified mechanisms that lead to the increased conductance. Similarly, in current-clamp recordings from PCs in the absence of pharmacological agents, glial ArchT photoactivation was introduced after burst firing emerged upon OGD ( Figure 4B ). Without the photoactivation, PCs soon reached plateau depolarization, whereas photoactivation suppressed this indication of cell deterioration.
Could simply countering acidosis with glial alkalization exert a neuroprotective action upon ischemia? To answer this question, ischemia in the cerebellum in vivo was created by using a photosensitive dye, rose bengal (Watson et al., 1985) . Rose bengal was injected intra-arterially and focal ischemic region was created by exciting this dye via an optic fiber placed above the cerebellum and thrombosis was artificially created. Three hours after creation of thrombosis, severe neuronal degeneration was confirmed ( Figure 4C) . To quantify the level of damage, we scored brain sections based on the relative loss of PCs and the degenerated area ( Figure S4 ). In one group of mice, glial ArchT photoactivation was intermittently applied from 0.5 to 2.5 hr after the creation of thrombosis. In this group, progressive generation of infarct area was significantly inhibited at 3 hr from photothrombosis ( Figures 4D and 4E) . These results demonstrate that countering of astrocyte acidosis can reduce brain damage upon ischemia.
DISCUSSION
Evidence for glia modulating neuronal activity (Panatier et al., 2011; Saab et al., 2012) and glutamate being used as gliotransmitter is accumulating (Woo et al., 2012) ; however, the mechanism of its release remains to be elucidated. Several reports have indicated that the release is Ca 2+ dependent (Halassa and Haydon, 2010) , although functional significance of glial Ca 2+ has also been questioned (Agulhon et al., 2010; Sun et al., 2013) . Here, we propose that glial pH changes are a significant regulator of glutamate release in the cerebellum. We focused on the cerebellum because of the close morphological apposition of glial and neuronal elements that suggests that, if there is any commitment of glial cell activities in physiological or pathophysiological circumstances, it could manifest most in the cerebellum. As pH-dependent glial ATP release has also been shown (Gourine et al., 2010) , pH could be a key glial intracellular signal, which is as pivotal as Ca 2+ , although the relative importance of pH may differ among different brain regions (Kasymov et al., 2013) .
It should be noted that we are not proposing that H + -triggered glial glutamate release is the only mechanism underlying liberation of excess glutamate upon ischemia. Most of the current experiments were done in TTX and Cd 2+ to focus on the glial component, but neurons have also been shown to release glutamate during the initial stage of ischemia by vesicular release, and reversal of neuronal and glial glutamate transporters has also been shown to occur (Gebhardt et al., 2002; Hamann et al., 2005; Rossi et al., 2007) . The relative role of each component is difficult to assess, as blocking one component will also disrupt the interplay between all components. However, our data do show that suppression of glial glutamate release alone by glial ArchT photoactivation can sustain hyperpolarization of neurons in half of the cells in slices in the absence of all pharmacological agents for some time ( Figure 4B ) and save the brain from large structural damage in vivo ( Figure 4D ). Direct application of our findings in patients is limited, as it would require preemptive gene therapy before ischemia. However, our data do show that countering of glial acidosis alone can powerfully suppress ischemic brain damage, which suggests that pH-dependent glial glutamate release is one of the pathways leading to excitotoxic cell death. Therapeutic strategy could involve simple delivering of cell-permeable strong pH buffer or pharmacological agents directed to facilitate H + exchange. As glial ChR2-photoactivated PC current was not sensitive to NPPB , the glutamate release mechanism is not likely to be via Best1 (Woo et al., 2012) . Other various anion channels and transporters have been reported to deliver glutamate to extracellular space with different pharmacological characteristics (Fields and Ni, 2010) ; however, most of their molecular identity has not been specified. If we are able to find which channel or transporter is involved in the pH-dependent glial glutamate release, targeted drug design would become plausible.
EXPERIMENTAL PROCEDURES
All experiments were performed in accordance with the guidelines of the Physiological Society of Japan.
Electrophysiology
Acute slice preparation and whole-cell patch-clamp recording were performed as described previously . To simulate energy deprivation upon brain ischemia, we omitted glucose and superfusate bubbled with 95% N 2 , 5% CO 2 was used. For most experiments, photostimulation was delivered to the slices through the objective lens, but for the ArchT activation during pH imaging, photostimulation was given through the condenser lens as described in the Supplemental Experimental Procedures.
pH Imaging Cells were loaded with local puff application of SNARF-5F AM. In most recordings, SNARF-5F was excited with 810 nm two-photon laser and fluorescence was detected using two emission filters (586/20 nm and 650/60 nm) and the fluorescence ratio (R 650/586 ) was calculated. Details are described in Supplemental Experimental Procedures.
Optogenetic Mice tetO-ChR2(C128S)-EYFP b-actin gene locus knockin mice , tetO-ArchT-EGFP b-actin gene BAC transgenic mice (Tsunematsu et al., 2013) , and astrocyte specific Mlc1-tTA mice Tanaka et al., 2010) were used. Bigenic mice were created by crossing the Mlc1-tTA with either of the tetO lines. Details are described in the Supplemental Experimental Procedures.
Immunogold Electron Microscopy of Mlc1-tTA::tetO-ArchT-EGFP Mice Tissue processing for preembedding immunoelectron microscopy was performed as described previously (Parajuli et al., 2012) . Mouse anti-GFP antibody (1 mg/ml, Clone mFX73, Wako) was used as a primary antibody, and enhancement of the immunogold particles was carried out by using a gold enhance-EM kit (Nanoprobes). Details are described in the Supplemental Experimental Procedures.
Creation of Cerebellar Ischemia Model and In Vivo Glial ArchT Photoactivation
Rose bengal was administrated through the left carotid artery (Watson et al., 1985) and the dye was excited for 4-5 min via an optical fiber placed just above the craniotomy made over the cerebellum. A group of mice was given intermittent glial ArchT photoactivation (1 s light on, 1 s light off cycle for 2.5 hr), which started after 30 min from the photothrombosis. The mice were sacrificed after 3 hr from the photothrombosis. Details of the evaluation of the infarct area are described in the Supplemental Experimental Procedures. 
SUPPLEMENTAL INFORMATION
